Gemphire Therapeutics: Gemphire Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

(marketscreener.com) LIVONIA, Mich., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life-threatening cardiovascular disease, focused on orphan indications, as...http://www.marketscreener.com/GEMPHIRE-THERAPEUTICS-INC-28734724/news/Gemphire-Therapeutics-Reports-Second-Quarter-2019-Financial-Results-and-Provides-Corporate-Update-29040570/?utm_medium=RSS&utm_content=20190809